Active Ingredient(s): Sonidegib
FDA Approved: * July 24, 2015
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Odomzo Overview

Sonidegib (INN), sold under the brand name Odomzo, is a medication used to treat cancer.[2] Sonidegib is Hedgehog signaling pathway inhibitor (via smoothened antagonism).[3][4] Contents 1 Approvals and indications 2 Pharmacology 3 Development 4 References 5 External links Approvals and indications It was approved for medical use in the United States and in the European Union in 2015[5][6][7]...

Read more Odomzo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sonidegib

Recent Odomzo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 200mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Odomzo: (2 results)

Sorted by National Drug Code
  • 0078-0645 Odomzo 200 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 47335-303 Odomzo 200 mg Oral Capsule by Sun Pharma Global Fze

Other drugs which contain Sonidegib or a similar ingredient: (1 result)